Targeting of promising transmembrane proteins for diagnosis and treatment of pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is one of the most fatal types of cancer due to the relatively late diagnosis and the limited therapeutic options. Current treatment regimens mainly comprise the cytotoxic agents gemcitabine and FOLFIRINOX. These compounds have shown limited efficacy and sever...

Descripción completa

Detalles Bibliográficos
Autores principales: Mashayekhi, Vida, Mocellin, Orsola, Fens, Marcel H.A.M., Krijger, Gerard C., Brosens, Lodewijk A.A., Oliveira, Sabrina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419040/
https://www.ncbi.nlm.nih.gov/pubmed/34522225
http://dx.doi.org/10.7150/thno.60350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419040/
https://www.ncbi.nlm.nih.gov/pubmed/34522225
http://dx.doi.org/10.7150/thno.60350

Ejemplares similares